Literature DB >> 1677420

CSF changes in a longitudinal study of 124 neurologically normal HIV-1-infected U.S. Air Force personnel.

D W Marshall1, R L Brey, C A Butzin, D R Lucey, S M Abbadessa, R N Boswell.   

Abstract

Over a 2 year period, 124 neurologically normal HIV-1-infected patients had three successive cerebrospinal fluid (CSF) examinations approximately 1 year apart. Immunological status as measured by absolute CD4 counts in the blood identified two groups of patients over time: (a) a group with progressive CD4 decline (66 patients), and (b) a group with stable CD4 counts (58 patients). These two study groups provided us the opportunity to compare CSF changes (cells, protein, albumin index, IgG, IgG index, and IgG synthesis rate) in neurologically normal individuals with respect to immunological status over time. We found significantly increased intrathecal cellular response and IgG production over time independent of CD4 group. We conclude that any clinical study comparing CSF findings in neurologically symptomatic HIV-infected individuals must recognize and control for these CSF changes in neurologically asymptomatic patients.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1677420

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr (1988)        ISSN: 0894-9255


  16 in total

1.  Blood-brain barrier tight junction disruption in human immunodeficiency virus-1 encephalitis.

Authors:  L M Dallasta; L A Pisarov; J E Esplen; J V Werley; A V Moses; J A Nelson; C L Achim
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

2.  Prevalence and predictors of blood-brain barrier damage in the HAART era.

Authors:  A Calcagno; M C Alberione; A Romito; D Imperiale; V Ghisetti; S Audagnotto; F Lipani; S Raviolo; G Di Perri; S Bonora
Journal:  J Neurovirol       Date:  2014-06-28       Impact factor: 2.643

Review 3.  Immune modulation by estrogens: role in CNS HIV-1 infection.

Authors:  Melinda E Wilson; Filomena O Dimayuga; Janelle L Reed; Thomas E Curry; Carol F Anderson; Avindra Nath; Annadora J Bruce-Keller
Journal:  Endocrine       Date:  2006-04       Impact factor: 3.633

4.  Dynamic of CSF and serum biomarkers in HIV-1 subtype C encephalitis with CNS genetic compartmentalization-case study.

Authors:  Sergio M de Almeida; Indianara Rotta; Clea E Ribeiro; Michelli F Oliveira; Antoine Chaillon; Ana Paula de Pereira; Ana Paula Cunha; Marise Zonta; Joao França Bents; Sonia M Raboni; Davey Smith; Scott Letendre; Ronald J Ellis
Journal:  J Neurovirol       Date:  2017-02-28       Impact factor: 2.643

5.  Detection of Treponema pallidum Sp. Pallidum DNA in Cerebrospinal Fluid (CSF) by Two PCR Techniques.

Authors:  Rita Castro; Maria João Águas; Teresa Batista; Carlos Araújo; Kamal Mansinho; Filomena da Luz Martins Pereira
Journal:  J Clin Lab Anal       Date:  2016-02-18       Impact factor: 2.352

Review 6.  NeuroAIDS: characteristics and diagnosis of the neurological complications of AIDS.

Authors:  Alireza Minagar; Deborah Commins; J Steven Alexander; Romy Hoque; Francesco Chiappelli; Elyse J Singer; Behrooz Nikbin; Paul Shapshak
Journal:  Mol Diagn Ther       Date:  2008       Impact factor: 4.074

Review 7.  Cerebrospinal fluid (CSF) analyses in HIV-1 primary neurological disease.

Authors:  J Nogales-Gaete; K Syndulko; W W Tourtellotte
Journal:  Ital J Neurol Sci       Date:  1992-11

8.  Human immunodeficiency virus type 1 tat-mediated cytotoxicity of human brain microvascular endothelial cells.

Authors:  Naveed Ahmed Khan; Francescopaolo Di Cello; Avi Nath; Kwang Sik Kim
Journal:  J Neurovirol       Date:  2003-12       Impact factor: 2.643

9.  Cannabinoids inhibit HIV-1 Gp120-mediated insults in brain microvascular endothelial cells.

Authors:  Tzong-Shi Lu; Hava Karsenty Avraham; Seyha Seng; Souvenir D Tachado; Henry Koziel; Alexandros Makriyannis; Shalom Avraham
Journal:  J Immunol       Date:  2008-11-01       Impact factor: 5.422

Review 10.  Human immunodeficiency virus type 1 infection of the brain.

Authors:  W J Atwood; J R Berger; R Kaderman; C S Tornatore; E O Major
Journal:  Clin Microbiol Rev       Date:  1993-10       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.